Health Care & Life Sciences » Pharmaceuticals | Sumitomo Dainippon Pharma Co. Ltd.

Sumitomo Dainippon Pharma Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
104,698
141,846
135,961
105,603
147,775
137,296
Total Accounts Receivable
153,262
152,124
155,591
118,966
113,401
119,243
Inventories
59,141
62,387
59,587
60,286
60,169
66,889
Other Current Assets
42,510
45,342
70,445
22,705
27,236
49,840
Total Current Assets
359,611
401,699
421,584
307,560
348,581
373,268
Net Property, Plant & Equipment
72,689
65,160
61,824
61,121
58,204
59,485
Total Investments and Advances
50,823
58,149
60,392
-
-
-
Intangible Assets
156,796
173,863
156,580
297,308
284,778
270,738
Other Assets
10,511
7,918
5,022
55,994
76,513
80,507
Total Assets
659,032
711,583
707,715
779,072
809,684
834,717
ST Debt & Current Portion LT Debt
10,006
36,522
23,010
58,749
17,162
Accounts Payable
11,713
12,492
12,153
14,514
17,512
Income Tax Payable
10,524
3,288
26,357
10,001
14,368
Other Current Liabilities
98,964
104,541
118,202
148,869
161,206
Total Current Liabilities
131,207
156,843
179,722
232,133
210,248
Long-Term Debt
90,181
55,756
33,991
11,778
32,390
Provision for Risks & Charges
13,892
15,274
16,158
16,374
20,700
Deferred Taxes
7,102
12,560
13,896
57,017
41,513
Other Liabilities
9,508
15,335
15,163
106,447
93,528
Total Liabilities
260,492
260,562
261,243
366,804
356,961
Common Equity (Total)
398,540
451,021
446,472
412,268
452,723
Total Shareholders' Equity
398,540
451,021
446,472
412,268
452,723
Total Equity
398,540
451,021
446,472
412,268
452,723
Liabilities & Shareholders' Equity
659,032
711,583
707,715
779,072
809,684

About Sumitomo Dainippon Pharma Co.

View Profile
Address
2-6-8 Dosho-machi
Osaka Osaka 541
Japan
Employees -
Website http://www.ds-pharma.co.jp
Updated 07/08/2019
Sumitomo Dainippon Pharma Co., Ltd. engages in manufacturing, sale, import and export of pharmaceuticals products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment handles the creation of new pharmaceutical products.